AXA World Funds - Longevity Economy I Capitalisation USDRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 11.0 | 10.4 | -4.0 | 1.4 | 6.1 | |
+/-Cat | -6.5 | 1.0 | 0.6 | 4.5 | 0.9 | |
+/-B’mrk | - | -7.8 | -9.8 | 3.9 | -1.9 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 18/04/2024 | USD 123.45 | |
Day Change | -0.02% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | LU1830284219 | |
Fund Size (Mil) 18/04/2024 | USD 195.59 | |
Share Class Size (Mil) 18/04/2024 | USD 11.68 | |
Max Initial Charge | - | |
Ongoing Charge 30/06/2023 | 0.86% |
Investment Objective: AXA World Funds - Longevity Economy I Capitalisation USD |
To seek long-term growth of your investment, in USD, from an actively managed listed equity, equity-related securities, and derivatives portfolio, and to apply an ESG approach. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Stephen Kelly 04/07/2023 | ||
Gregg Bridger 04/07/2023 | ||
Inception Date 12/09/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR EUR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for AXA World Funds - Longevity Economy I Capitalisation USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.15 |
American Express Co | Financial Services | 3.05 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.96 |
Freshpet Inc | Consumer Defensive | 2.86 |
Abbott Laboratories | Healthcare | 2.66 |
Increase Decrease New since last portfolio | ||
AXA World Funds - Longevity Economy I Capitalisation USD |